Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk early breast cancer Seven-year results from the ...
How Does Verzenio Work for Metastatic Breast Cancer? Verzenio is a type of medicine called a kinase inhibitor. Kinases are enzymes in the body that can send and receive signals to help your cells do ...
Verzenio monotherapy provided clinical benefits to 33% of patients with HR-positive, HER2-negative breast cancer after prior CDK4/6 inhibitor therapy. The rAMBER study highlights Verzenio's potential ...
How Do I Take Verzenio for Early Breast Cancer? Verzenio is taken as a tablet that you will swallow. You take Verzenio twice a day, and you can take it with or without food. You should try to take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results